Asim Afaq
University College Hospital
Intraclass correlationCorrelationInternal medicineRadiologyPET-CTPathologyMagnetic resonance imagingUltrasoundOncologyStage (cooking)Medical physicsPositron emission tomographyProstateBiochemical recurrenceBrachytherapyMetastasisProstatectomyProstate cancerSalvage therapyProstate-specific antigenProstate BedNuclear medicineRadiation therapyColorectal cancerEffective diffusion coefficientMedicine
51Publications
14H-index
880Citations
Publications 49
Newest
#1Maira Hameed (Imperial College Healthcare)H-Index: 1
#2Balaji Ganeshan (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 3
Last. Deepak Batura (NWU: North-West University)H-Index: 9
view all 7 authors...
: Unfortunately, in the original article one co-author's name is missing. The co-author name and affiliation is given as follows.
Source
#1Asim AfaqH-Index: 14
#2Fergus V. GleesonH-Index: 58
Last. Jamshed Bomanji (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
view all 14 authors...
The purpose of these guidelines is to assist specialists in Nuclear Medicine and Radionuclide Radiology in recommending, performing, interpreting and reporting 18F-fluciclovine PET/computed tomography. It should be recognised that adherence to the guidance in this document will not assure an accurat
2 CitationsSource
#1Maira Hameed (Imperial College Healthcare)H-Index: 1
#2Balaji Ganeshan (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 32
Last. Deepak Batura (NWU: North-West University)H-Index: 9
view all 6 authors...
Purpose To determine if multiparametric MRI (mpMRI) derived filtration-histogram based texture analysis (TA) can differentiate between different Gleason scores (GS) and the D’Amico risk in prostate cancer.
7 CitationsSource
#1Vincenzo Militano (UCL: University College London)H-Index: 1
#2Asim AfaqH-Index: 14
Last. Jamshed BomanjiH-Index: 52
view all 3 authors...
AbstractThis case highlights that liposarcoma shows 68Ga–prostate-specific membrane antigen avidity and should be included in the differential diagnosis of patients with avid muscle lesions to avoid an incorrect diagnosis of metastasis.
Source
#1Medhat AkerH-Index: 2
#2Balaji Ganeshan (UCL: University College London)H-Index: 32
Last. Tan ArulampalamH-Index: 12
view all 6 authors...
BACKGROUND:A certain proportion of patients with locally advanced rectal cancer experience complete response after undergoing neoadjuvant chemoradiotherapy. These patients might be suitable for a conservative “watch and wait” approach, avoiding high-morbidity surgery. Texture analysis is a new modal
15 CitationsSource
#1Asim Afaq (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 14
#2Jamshed Bomanji (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 12
Introduction: There is an unmet clinical need for early, accurate imaging of recurrent prostate cancer to improve patient outcomes. Staging, by conventional bone scintigraphy and CT have become outdated. 68Ga-PSMA PET/CT imaging in this setting has developed rapidly, with widespread International adoption in line with evidence-based guidelines in this group of patients. Sources of data: A PubMed search of English language articles was performed using following keywords: PSMA, PET/CT, biochemical...
3 CitationsSource
#1Marilena RegaH-Index: 1
#1Marilena RegaH-Index: 4
Last. Harpreet Hyare (UCL Institute of Neurology)H-Index: 18
view all 11 authors...
1 CitationsSource
#1Athar Haroon (St Bartholomew's Hospital)H-Index: 5
#1Athar Haroon (St Bartholomew's Hospital)H-Index: 2
Last. Jamshed BomanjiH-Index: 52
view all 11 authors...
The objective of this study was to highlight the role of multimodality imaging and present the differential diagnosis of abnormal tracer accumulation in the prostate and periprostatic tissue. Our departments have performed molecular imaging of the prostate utilizing PET-CT and PET-MRI with a range of biomarkers including F-FDG, radiolabelled choline, Ga-DOTATATE PET-CT and Ga-PSMA images. We retrospectively reviewed the varying appearances of the prostate gland in different diseases and incident...
Source
#1Eugene J. Teoh (University of Oxford)H-Index: 11
#2David Bottomley (Leeds Teaching Hospitals NHS Trust)H-Index: 20
Last. Fergus V. Gleeson (University of Oxford)H-Index: 58
view all 18 authors...
165Background: Detection of the extent of local recurrence and of metastases in biochemical recurrence (BCR) of prostate cancer facilitates selection of appropriate treatment. The FALCON trial (NCT02578940) assessed the impact of 18F-fluciclovine PET/CT on the clinical management of men with BCR of prostate cancer following initial radical therapy. Methods: Men being considered for curative-intent salvage therapy following first BCR were recruited at 6 UK sites. Management plans were documented ...
2 CitationsSource
#1Asim Afaq (UCLH: University College Hospital)H-Index: 14
#1Asim Afaq (UCLH: University College Hospital)H-Index: 4
Last. Jamshed Bomanji (UCL: University College London)H-Index: 52
view all 10 authors...
: The objective of this study was to assess the impact of 68Ga-prostate-specific membrane antigen (68Ga-PSMA) PET/CT on the management of prostate cancer in patients with biochemical recurrence (BCR). Methods: Documented management plans before and after 68Ga-PSMA PET/CT in 100 patients with BCR were retrospectively reviewed, and changes in plans were recorded. Results: Management changed after 68Ga-PSMA PET/CT in 39 patients (39%). The management changes occurred in 23 (33.8%) of 68 patients wi...
39 CitationsSource